Rahul Kumar
Rahul Kumar
Indian Institute of Science (IISc), Bengaluru
Verified email at iisc.ac.in - Homepage
Cited by
Cited by
In silico approach for predicting toxicity of peptides and proteins
S Gupta, P Kapoor, K Chaudhary, A Gautam, R Kumar, GPS Raghava, ...
PloS one 8 (9), e73957, 2013
CPPsite: a curated database of cell penetrating peptides
A Gautam, H Singh, A Tyagi, K Chaudhary, R Kumar, P Kapoor, ...
Database 2012, 2012
In silico approaches for designing highly effective cell penetrating peptides
A Gautam, K Chaudhary, R Kumar, A Sharma, P Kapoor, A Tyagi, ...
Journal of translational medicine 11 (1), 74, 2013
In silico models for designing and discovering novel anticancer peptides
A Tyagi, P Kapoor, R Kumar, K Chaudhary, A Gautam, GPS Raghava
Scientific reports 3, 2984, 2013
CancerDR: cancer drug resistance database
R Kumar, K Chaudhary, S Gupta, H Singh, S Kumar, A Gautam, P Kapoor, ...
Scientific reports 3, 1445, 2013
TumorHoPe: a database of tumor homing peptides
P Kapoor, H Singh, A Gautam, K Chaudhary, R Kumar, GPS Raghava
PLoS One 7 (4), e35187, 2012
Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics
A Gautam, P Kapoor, K Chaudhary, R Kumar, GPS Raghava, ...
Current medicinal chemistry 21 (21), 2367-2391, 2014
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ...
Nature communications 9 (1), 1-16, 2018
The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers
B Weigelt*, R Bi*, R Kumar*, P Blecua, DL Mandelker, FC Geyer, F Pareja, ...
JNCI: Journal of the National Cancer Institute 110 (9), 1030-1034, 2018
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells
J Nikkilä, R Kumar, J Campbell, I Brandsma, HN Pemberton, F Wallberg, ...
British journal of cancer 117 (1), 113-123, 2017
An in silico platform for predicting, screening and designing of antihypertensive peptides
R Kumar, K Chaudhary, JS Chauhan, G Nagpal, R Kumar, M Sharma, ...
Scientific reports 5, 12512, 2015
Computational approach for designing tumor homing peptides
A Sharma, P Kapoor, A Gautam, K Chaudhary, R Kumar, JS Chauhan, ...
Scientific reports 3, 1607, 2013
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer
I Bajrami, R Marlow, M van de Ven, R Brough, HN Pemberton, J Frankum, ...
Cancer Discovery 8 (4), 498-515, 2018
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors
F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ADC Paula, ...
Nature communications 9 (1), 1-13, 2018
dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes
JS Nanda, R Kumar, GPS Raghava
Scientific reports 6, 19340, 2016
Herceptin resistance database for understanding mechanism of resistance in breast cancer patients
S Ahmad, S Gupta, R Kumar, GC Varshney, GPS Raghava
Scientific reports 4, 4483, 2014
The genomic landscape of mucinous breast cancer
F Pareja, JY Lee, DN Brown, S Piscuoglio, R Gularte-Mérida, P Selenica, ...
JNCI: Journal of the National Cancer Institute 111 (7), 737-741, 2019
Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
S Gupta, K Chaudhary, R Kumar, A Gautam, JS Nanda, SK Dhanda, ...
Scientific reports 6, 23857, 2016
Computer-aided virtual screening and designing of cell-penetrating peptides
A Gautam, K Chaudhary, R Kumar, GPS Raghava
Cell-Penetrating Peptides, 59-69, 2015
Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
H Singh, R Kumar, S Singh, K Chaudhary, A Gautam, GPS Raghava
BMC cancer 16 (1), 77, 2016
The system can't perform the operation now. Try again later.
Articles 1–20